Table 3.

Distribution of patients

	PVE group	PVL group
CRC	656(42.81 %)	64 (68.81 %)
Primary HPB malignancies	660 (43.08 %)	11 (11.82 %)
–	- HCC :214	- HCC :2
	- GB Ca:139	- CC : 9
	- CC :307 s
OM	195 (12.73 %)	–
NET	21 (1.37 %)	18 (19.35 %)
Hemangiomas	- NET : 14	- NET :18
Benign	- Benign/Misc: 06
Misc Lesions	- Hemangioma: 01
	1532	93

CRC colorectal metastases, CCA cholangiocarcinoma, OM other metastases, HCC hepatocellular carcinoma, GB Ca carcinoma gall bladder, NET Neuroendocrine tumours, Misc Miscellaneous lesion